Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function

P W Mathieson, C G Maidment, D J Evans, A J Rees, A Neil Turner

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Eight patients with idiopathic membranous nephropathy whose renal function was deteriorating were given a 6-month course of alternating monthly cycles of prednisolone and chlorambucil. Proteinuria was reduced in all eight, from a mean (SD) of 15.3 (5.9) g/24 h at the start of treatment to 2.1 (1.5) g/24 h at follow-up (p less than 0.05). Creatinine clearance increased in six, and the rate of decline was reduced in the other two (group mean 51.6 [17.8] ml/min at the start of treatment and 81.4 [36.8] ml/min at follow-up; p less than 0.05). Adverse effects of chlorambucil were severe, and the daily dose had to be reduced. Prednisolone and chlorambucil treatment can change the natural course of membranous nephropathy even when renal function has started to deteriorate, so treatment can be reserved for high-risk patients.

Original languageEnglish
Pages (from-to)869-72
Number of pages4
JournalThe Lancet
Volume2
Issue number8616
Publication statusPublished - 15 Oct 1988

Keywords / Materials (for Non-textual outputs)

  • Adult
  • Chlorambucil
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Follow-Up Studies
  • Glomerulonephritis, Membranous
  • Humans
  • Male
  • Middle Aged
  • Nephrotic Syndrome
  • Pancytopenia
  • Prednisolone
  • Proteinuria
  • Risk Factors

Fingerprint

Dive into the research topics of 'Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function'. Together they form a unique fingerprint.

Cite this